| Huo, Yong |
IMPROVE-AMI, NCT06683131: Effectiveness of Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients |
|
|
| Not yet recruiting | 4 | 1160 | RoW | Tafolecimab | The Affiliated Hospital of Xuzhou Medical University | Acute Myocardial Infarction (AMI) | 11/27 | 11/27 | | |
CSPPT2-CC/CT, NCT04974138: China Stroke Primary Prevention Trial 2 for Participants with H-type Hypertension and MTHFR 677 CC/CT Genotype |
|
|
| Recruiting | 4 | 32000 | RoW | Amlodipine besylate, Amlodipine, Amlodipine besylate and folic acid, Amlodipine folic acid, Anye, Amlodipine placebos, Amlodipine (dummy), Amlodipine-folic acid placebos, Amlodipine-folic acid (dummy) | Shenzhen Ausa Pharmed Co.,Ltd, Peking University First Hospital, Second Affiliated Hospital of Nanchang University, The First People's Hospital of Lianyungang, The Affiliated Hospital Of Guizhou Medical University, Lianyungang Oriental Hospital, Tengzhou Central People's Hospital, First Affiliated Hospital Bengbu Medical College, H & J CRO International, Inc., Shenzhen Prospective Medical Technology Co., LTD | Hypertension, MTHFR 677 CC or CT Genotype, Elevated Plasma Homocysteine (Hcy≥10µmol/L), Insufficient Plasma Folate Levels (<12ng/mL) | 06/29 | 06/29 | | |
NCT04709536: A Study of IBI306 in Participants With Hypercholesterolemia |
|
|
| Completed | 3 | 306 | RoW | IBI306, Placebo | Innovent Biologics (Suzhou) Co. Ltd. | Hypercholesterolemia | 11/21 | 01/22 | | |
NCT05255094: A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia |
|
|
| Recruiting | 3 | 450 | RoW | AK102, Placebo | Akeso | Hyperlipidemia | 04/22 | 07/22 | | |
NCT06568471: A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia |
|
|
| Recruiting | 3 | 210 | RoW | Lerodalcibep, HST101, LIB003, matching placebo | Hasten Biopharmaceutical Co., Ltd. | Hypercholesterolemia, Dyslipidemias, Primary Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia, Hyperlipidemia; Mixed, Metabolic Disease, ASCVD | 02/26 | 05/26 | | |
EVEREST, NCT06531161: EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill |
|
|
| Not yet recruiting | 2/3 | 168 | NA | Suxiao Jiuxin Pill, Placebo | Peking University First Hospital, Tibet Autonomous Region Hospital of Traditional Tibetan Medicine | Acute Mountain Sickness | 09/24 | 09/25 | | |
NCT05475717: A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI |
|
|
| Terminated | 2 | 132 | RoW | Alprostadil liposome injection, Alprostadil liposome | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Contrast-induced Acute Kidney Injury | 12/23 | 01/24 | | |
NCT02133287: To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization |
|
|
| Active, not recruiting | N/A | 2000 | RoW | AVI® Arsenic trioxide drug eluting stent delivery system, Firebird2® sirolimus eluting stent system | Beijing AmsinoMed Medical Device Co., Ltd | Ischemic Heart Disease, Myocardial Ischemia, Coronary Disease, Acute Coronary Syndrome | 06/18 | 11/22 | | |
NCT03716011: A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT |
|
|
| Not yet recruiting | N/A | 2700 | RoW | EXCROSSAL | JW Medical Systems Ltd | Coronary Artery Disease | 12/21 | 12/25 | | |
| Active, not recruiting | N/A | 220 | RoW | SyMapCath I™ catheter and SYMPIONEER S1™ Stimulator/Generator | SyMap Medical (Suzhou), Ltd., Tigermed Consulting Co., Ltd | Hypertension | 08/22 | 12/26 | | |
AFOSA, NCT04519489: The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA |
|
|
| Recruiting | N/A | 129 | RoW | PAP therapy with telemonitoring, AF standard management and OSA general care | Philips (China) Investment CO., LTD, Peking University First Hospital, Beijing Tsinghua Changgung Hospital, Beijing Tongren Hospital, Fu Wai Hospital, Beijing, China, Shanghai 6th People's Hospital, Ruijin Hospital | Atrial Fibrillation, Obstructive Sleep Apnea | 03/23 | 03/23 | | |
| Recruiting | N/A | 2132 | RoW | caFFR, Coronary Angiography-Derived Fractional Flow Reserve, FFR, Fractional Flow Reserve | Peking University First Hospital, Rainmed Ltd., Suzhou, China | Coronary Artery Disease, Coronary Stenosis, Myocardial Ischaemia, Coronary Circulation, Stable Angina Pectoris, Unstable Angina Pectoris, Asymptomatic Ischemia, Acute Myocardial Infarction, Percutaneous Coronary Intervention | 12/23 | 12/25 | | |
NCT05782881: High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program |
|
|
| Recruiting | N/A | 16000 | RoW | phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2 | Wuhan Union Hospital, China, Peking University First Hospital | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease | 12/23 | 12/24 | | |
NCT04861363: Follow up of Ticagrelor Treatment Patterns in Chinese Acute Coronary Syndromes Patients |
|
|
| Enrolling by invitation | N/A | 20000 | RoW | | Peking University First Hospital | Acute Coronary Syndrome | 07/21 | 07/21 | | |
